Cadrenal Starts Clinical Trial for Tecarfarin in ESKD Patients
Advances knowledge about the use of tecarfarin in patients with severe kidney impairment, including dialysis Pivotal step forward in pursuit of ESKD + Atrial Fibrillation...
Category : Clinical Research, Pharma & Healthcare Financing
MiRus Gets NTAP for EUROPA™ Posterior Cervical Fusion System
MiRus has received New Technology Add-on Payment (NTAP) from the Centers for Medicare and Medicaid Services (CMS) for the EUROPA® Posterior Cervical System, based on it’s...
Anbogen Gets FDA Nod for Phase 1/2 Colorectal Cancer Trial
Anbogen Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for ABT-301, enabling the initiation...
Alveolus Bio Gets Investment to Advance Lung Therapies
Shilpa Medicare Serves as Lead Investor, Positioning Alveolus Bio for Phase 2 Clinical Trials and First-in-Human Studies Alveolus Bio, a pioneering respiratory drug development biotech...
BeOne’s BGB-16673 Gets EMA PRIME for Waldenstrom’s
Decision highlights the promise of BGB-16673, an investigational and potentially first-in-class BTK degrader designed to overcome resistance and deepen responses in B-cell malignancies BeOne Medicines...
Cotiviti Earns 25th Year of HEDIS® Certification
HEDIS measures embedded in Cotiviti’s Quality Intelligence pass NCQA’s validation process for Measurement Year (MY) 2025 Quality Engine, the administrative measure logic and sample processing...
Trial of Blood Test for 10 Cancers Hits Key Milestone
MODERNISED (NIHR207538), a multi-site UK clinical study has passed a key milestone: over 450 participants have joined the trial evaluating ENLIGHTEN®, a first-of-its-kind blood test, registered with...
Akeso Completes First Dosing in Phase III NSCLC Trial
Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) announced that the first patient has been dosed in its pivotal Phase III clinical study (AK112-305/HARMONi-8A) of ivonescimab...
ESTEVE Acquires Regis Technologies, Boosts U.S. Presence
This acquisition enables ESTEVE to expand its contract development and manufacturing services for small-molecule active pharmaceutical ingredients from pre-clinical to commercial manufacturing in the US. ...
Viridian, Kissei Ink $70M+ Deal for Eye Drug in Japan
– Kissei obtains an exclusive license to develop and commercialize veligrotug and VRDN-003 in Japan – – Viridian to receive an upfront payment of $70...
NeoGenomics Launches PanTracer LBx Liquid Biopsy Test
New ctDNA-based test offers a flexible, guideline-driven solution for patients with advanced solid tumors when tissue is limited or unavailable NeoGenomics, Inc. (NASDAQ: NEO), a...
WuXi Biologics Singapore Launches Modular Drug Facility
WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced construction has begun for a new modular Drug Product (DP) facility,...
Lilly’s Jaypirca Beats Imbruvica in Phase 3 CLL/SLL Trial
Pirtobrutinib met the primary endpoint of response rate non-inferiority, favoring pirtobrutinib with a nominal P-value for superiority < 0.05 Progression-free survival data was immature, but...
Kinvard Bio Gets Follow-on CARB-X Funding for New Antibiotics
Non-dilutive funding advances development of differentiated ribosome-targeting antibiotics for serious, drug-resistant infections with high unmet patient need Kinvard Bio Inc., a biotechnology company pioneering a next-generation class...
Azafaros Starts Phase 3 Trials for Rare Neuro Disorders
Azafaros, a company focused on developing treatments for the unmet needs of patients with rare lysosomal storage disorders, today announced that the first patient has...